| Mar'20 | Mar'19 | |||||
|---|---|---|---|---|---|---|
Costs and operating expenses: | ||||||
Research and development | ||||||
24,836 | 17,493 | |||||
Selling, general and administrative | ||||||
20,145 | 10,790 | |||||
Total costs and operating expenses | ||||||
44,981 | 28,283 | |||||
Loss from operations | ||||||
-44,981 | -28,283 | |||||
Other income (expense): | ||||||
Interest income | ||||||
1,480 | 1,623 | |||||
Interest expense | ||||||
613 | - | |||||
Other income (expense), net | ||||||
-6,790 | -3,486 | |||||
Total other income (expense), net | ||||||
-5,923 | -1,863 | |||||
Net loss before income tax | ||||||
-50,904 | -30,146 | |||||
Income tax (expense) benefit | ||||||
-300 | 600 | |||||
Net loss attributable to ordinary shareholders | ||||||
-50,569 | -30,739 | |||||
Other comprehensive income (loss): | ||||||
Foreign currency translation adjustment | ||||||
6,034 | 3,051 | |||||
Unrealized loss on marketable securities | ||||||
-1,021 | - | |||||
Total other comprehensive income (loss): | ||||||
5,013 | 3,051 | |||||
Total comprehensive loss | ||||||
-45,556 | -27,688 | |||||
Net loss per share attributable to ordinary shareholders, basic and diluted | ||||||
-0.51 | -0.35 | |||||
Weighted average number of ordinary shares outstanding, basic and diluted | ||||||
98,713 | 87,010 | |||||